BIOHIT GROUP HALF YEAR FINANCIAL REPORT 2022
Biohit Oyj Half Year Financial Report 10 August 2022 at 9:30 am local time (EET) SUMMARY January-June 2022 · Revenue EUR 6.1 million (EUR 4.0 million) · Revenue increased by 53% compared to H1/2021 · Operative EBITDA EUR 1.7 million (EUR -0.2 million) · Cash at the end of the period EUR 1.6 million (EUR 1.1 million 31 December 2021) · Fair value of Genetic Analysis AS investment EUR 0.4 million (EUR 0.9 million 31 December 2021) · Revenue from international operations 98.2% (97.2%) of total revenue · Equity ratio 70.7% (76.3% 31 December 2021) BIOHIT GROUP